Croissy-Beaubourg, January 11, 2021, 5:45pm CET – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics and theranostics, today announces that it has obtained CE marking for four additional i-Tracker® test kits…
Croissy-Beaubourg, December 15, 2020, 5.45pm CET – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics of autoimmune diseases and theranostics, today announces its schedule for the publication of financial information for…
Croissy-Beaubourg, December 14, 2020 – 8.00 am CET – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics and theranostics, announces the publication of a study that meets French National Authority for…